Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 12:14 PM
Ignite Modification Date:
2025-12-26 @ 12:14 PM
NCT ID:
NCT06207500
Brief Summary:
Background:
Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk.
Objective:
The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise.
The main questions to be answered were:
* the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge
* the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge.
Participants in the intervention group were offered the following:
* medication reconciliation on admission
* medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists.
Participants in the control group were offered standard care.
Detailed Description:
Design: pragmatic, prospective, controlled clinical trial
Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia:
* one intervention ward with a routine pharmacist-led medication reconciliation service
* four control wards
Data collection:
* Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients.
* Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation.
* The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity.
* Patient comorbidity was assessed using the Charlson Comorbidity Index
* For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records
* Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview.
Study:
NCT06207500
Study Brief:
Protocol Section:
NCT06207500